Cargando…
P-089: EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS.
Autores principales: | S., BHATT, A., RAJESH, A., BHANSALI, N., BENEDICT, S., MEHER, P., PANDA, B., DASH, S., KUNDU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429845/ http://dx.doi.org/10.1097/01.HS9.0000873244.82673.8b |
Ejemplares similares
-
P-092: RED BLOOD CELL GLUCOSE CONSUMPTION AND METABOLISM IN SICKLE CELL DISEASE
por: A., RAJESH, et al.
Publicado: (2022) -
P-101: REMEDIAL EFFECT OF GUDUCHI SATWA IN SICKLE RED BLOOD CELLS – AN AYURVEDIC APPROACH
por: A., RAJESH, et al.
Publicado: (2022) -
HbS-Sicilian (δβ)(0)-Thalassemia: A Rare Variant of Sickle Cell
por: Onimoe, Grace, et al.
Publicado: (2017) -
HbS Binding to GP1bα Activates Platelets in Sickle Cell Disease
por: Annarapu, Gowtham K., et al.
Publicado: (2016) -
Ingenious ISOLDE
Publicado: (1979)